AIDS, HIV & STDs

MarketReports.com | Pharmaceuticals & Healthcare | Diseases and Treatment |  AIDS, HIV & STDs

Syphilis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Price Single User $3,995.00 Site License $7,990.00 Global Site License $11,985.00 Publication Date: 29-Feb-2012 Format: PDF Pages: 50 Publisher: GlobalData More...

Gonorrhea Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Price Single User $3,995.00 Site License $7,990.00 Global Site License $11,985.00 Publication Date: 31-Mar-2012 Format: PDF Pages: 48 Publisher: GlobalData More...

HIV-Associated Diarrhea Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Price Single User $3,995.00 Site License $7,990.00 Global Site License $11,985.00 Publication Date: 29-Feb-2012 Format: PDF Pages: 53 Publisher: GlobalData More...

HIV / AIDS – Pipeline Review, H1 2012 Price Single User $500.00 Site License $1,000.00 Global Site License $1,500.00 Publication Date: 27-Feb-2012 Format: PDF Pages: 456 Publisher: Global Markets Direct More...

HIV-1 Infection – Pipeline Review, H1 2012 Price Single User $500.00 Site License $1,000.00 Global Site License $1,500.00 Publication Date: 27-Feb-2012 Format: PDF Pages: 260 Publisher: Global Markets Direct More...

HIV/AIDS Therapeutics Market to 2017 - Superior Combination Therapies and Decreasing Mortality to Sustain Market Growth Despite Major Patent Expiries Price Single User $3,500.00 Site License $7,000.00 Global Site License $10,500.00 Publication Date: 03-Oct-2011 Format: PDF Pages: 96 Publisher: GBI Research More...

Competitor Analysis: HIV Small Molecule Therapeutics Price Single User $642.00 Site License $1,284.00 Global License $1,926.00 Publication Date: Dec 2011 Format: PDF Pages: 100 Publisher: La Merie The present Competitive Intelligence report about HIV Small Molecule Therapeutics used to treat human immunodeficiency virus (HIV) infections provides a competitor evaluation in the field of marketed products and R&D projects of HIV small molecule therapeutics as of December 2011. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report. More...

Genital Herpes Therapeutics - Pipeline Assessment and Market Forecasts to 2017 Price Single User $2,000.00 Site License $4,000.00 Global Site License $6,000.00 Publication Date: May-2011 Format: PDF Pages: 73 Publisher: GlobalData More...

AIDS-related Kaposi’s Sarcoma (ARKS) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 Price Single User $2,000.00 Site License $4,000.00 Global Site License $6,000.00 Publication Date: 03-Jun-2011 Format: PDF Pages: 60 Publisher: GlobalData More...

Chlamydia Infections - Pipeline Review, Q2 2011 Price Single User $500.00 Site License $1,000.00 Global Site License $1,500.00 Publication Date: 26-May-2011 Format: PDF Pages: 37 Publisher: Global Markets Direct More...

HIV Pain - Pipeline Review, Q2 2011 Price Single User $500.00 Site License $1,000.00 Global Site License $1,500.00 Publication Date: 26-May-2011 Format: PDF Pages: 36 Publisher: Global Markets Direct More...

HIV-AIDS Therapeutics - Pipeline Assessment and Market Forecasts to 2017 Price Single User $2,000.00 Site License $4,000.00 Global Site License $6,000.00 Publication Date: 19-May-2011 Format: PDF Pages: 86 Publisher: GlobalData More...

R&D Trends: HIV - An active pipeline faces fierce competition in the HIV market Price: $3,800.00 (€2,994.94) ($4,560.00 (€3,593.93) Including VAT at 20%) Publication Date: 28-Mar-2011 Please click here for more information or to purchase this report at our partner store This module examines current trends in HIV drug development. It explores novel innovative strategies in HIV treatment and discusses recent developments in pre-exposure prophylaxis and vaccine development.

HIV-1 Infection - Pipeline Review, Q1 2011 Price Single User $500.00 Site License $1,000.00 Global Site License $1,500.00 Publication Date: 28-Feb-2011 Format: PDF Pages: 86 Publisher: Global Markets Direct More...

Genital Herpes - Pipeline Review, Q1 2011 Price Single User $500.00 Site License $1,000.00 Global Site License $1,500.00 Publication Date: 28-Feb-2011 Format: PDF Pages: 34 Publisher: Global Markets Direct More...

HIV / AIDS - Pipeline Review, Q1 2011 Price Single User $500.00 Site License $1,000.00 Global Site License $1,500.00 Publication Date: 28-Feb-2011 Format: PDF Pages: 355 Publisher: Global Markets Direct More...

Syphilis Global Clinical Trials Review, Q1, 2011 Price Single User $1,000.00 Site License $2,000.00 Global Site License $3,000.00 Publication Date: 28-Feb-2011 Format: PDF Pages: 26 Publisher: GlobalData More...

HIV-Associated Lipodystrophy Syndrome - Pipeline Review, Q1 2011 Price Single User $500.00 Site License $1,000.00 Global Site License $1,500.00 Publication Date: Jan-2011 Format: PDF Pages: 19 Publisher: Global Markets Direct More...

Aids Associated Dementia - Pipeline Review, Q1 2011 Price Single User $500.00 Site License $1,000.00 Global Site License $1,500.00 Publication Date: Jan-2011 Format: PDF Pages: 19 Publisher: Global Markets Direct More...

HIV-Related Lymphoma - Pipeline Review, Q1 2011 Price Single User $500.00 Site License $1,000.00 Global Site License $1,500.00 Publication Date: Jan-2011 Format: PDF Pages: 18 Publisher: Global Markets Direct More...

Aids-Related Kaposi's Sarcoma - Pipeline Review, Q1 2011 Price Single User $500.00 Site License $1,000.00 Global Site License $1,500.00 Publication Date: Jan-2011 Format: PDF Pages: 25 Publisher: Global Markets Direct More...

Aids - Related Cancers - Pipeline Review, Q4 2010 Price Single User $500.00 Site License $1,000.00 Global Site License $1,500.00 Publication Date: Dec-2010 Format: PDF Pages: 25 Publisher: Global Markets Direct More...

International AIDS Vaccine Initiative – Developmental Therapeutics Review – Q4 2010 Price Single User $500.00 Site License $1,000.00 Global Site License $1,500.00 Publication Date: Dec-2010 Format: PDF Pages: 52 Publisher: Global Markets Direct More...

St Stephens AIDS Trust – Developmental Therapeutics Review – Q4 2010 Price Single User $500.00 Site License $1,000.00 Global Site License $1,500.00 Publication Date: Dec-2010 Format: PDF Pages: 33 Publisher: Global Markets Direct More...

Stakeholder Opinions: Sexually Transmitted Diseases - An underestimated threat lacking interventions to prevent transmission Price: $3,800.00 (€2,994.94) ($4,560.00 (€3,593.93) Including VAT at 20%) Publication Date: 05-Aug-2010 Please click here for more information or to purchase this report at our partner store This report covers 4 STDs: chlamydia, gonorrhea, human papillomavirus (HPV), and herpes simplex virus type 2 (HSV-2). It discusses disease background, epidemiology, unmet needs as well as marketed and pipeline therapeutic and preventative strategies.

HIV Related Neurological Diseases - Pipeline Review, Q4 2010 Price Single User $500.00 Site License $1,000.00 Global Site License $1,500.00 Publication Date: 15-Nov-2010 Format: PDF Pages: 50 Publisher: Global Markets Direct More...

Genital Warts - Pipeline Review, Q4 2010 Price Single User $500.00 Site License $1,000.00 Global Site License $1,500.00 Publication Date: 15-Nov-2010 Format: PDF Pages: 50 Publisher: Global Markets Direct More...

HIV Pain - Pipeline Review, Q4 2010 Price Single User $500.00 Site License $1,000.00 Global Site License $1,500.00 Publication Date: 15-Nov-2010 Format: PDF Pages: 50 Publisher: Global Markets Direct More...

AIDS-Related Complex - Pipeline Review, Q4 2010 Price Single User $500.00 Site License $1,000.00 Global Site License $1,500.00 Publication Date: 15-Nov-2010 Format: PDF Pages: 50 Publisher: Global Markets Direct More...

HIV-2 Infection - Pipeline Review, Q4 2010 Price Single User $500.00 Site License $1,000.00 Global Site License $1,500.00 Publication Date: 15-Nov-2010 Format: PDF Pages: 50 Publisher: Global Markets Direct More...

HIV-1 Infection - Pipeline Review, Q4 2010 Price Single User $500.00 Site License $1,000.00 Global Site License $1,500.00 Publication Date: Dec-2010 Format: PDF Pages: 76 Publisher: Global Markets Direct More...

Genital Herpes - Pipeline Review, Q4 2010 Price Single User $500.00 Site License $1,000.00 Global Site License $1,500.00 Publication Date: Dec-2010 Format: PDF Pages: 41 Publisher: Global Markets Direct More...

French National Agency for Research on AIDS and Viral Hepatitis – Developmental Therapeutics Review – Q4 2010 Price Single User $500.00 Site License $1,000.00 Global Site License $1,500.00 Publication Date: Dec-2010 Format: PDF Pages: 97 Publisher: Global Markets Direct More...

HIV / AIDS - Pipeline Review, Q4 2010 Price Single User $500.00 Site License $1,000.00 Global Site License $1,500.00 Publication Date: Dec-2010 Format: PDF Pages: 383 Publisher: Global Markets Direct More...

Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity Price: $3,800.00 (€2,994.94) ($4,560.00 (€3,593.93) Including VAT at 20%) Publication Date: 25-May-2010 Please click here for more information or to purchase this report at our partner store This report analyzes three emerging markets, Brazil, Russia and India as targets for HIV drug manufacturers. It discusses the commercial and regulatory environment, guidelines, domestic and multinational competition as well as market entry strategies.

HIV-AIDS – Pipeline Assessment and Market Forecasts to 2016 Price Single User $2,000.00 Site License $4,000.00 Global Site License $6,000.00 Publication Date: 21-Jun-2010 Format: PDF Pages: 69 Publisher: GlobalData More...

The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis Price Single User $3,500.00 Site License $7,000.00 Global Site License $10,500.00 Publication Date: 30-Dec-2009 Format: PDF Pages: 101 Publisher: GBI Research More...

Global HIV Market: An Analysis Price: $700.00 (€551.70) ($840.00 (€662.04) Including VAT at 20%) Publication Date: 01-Feb-2009 Format: PDF Email Pages: 25 Publisher: Koncept Analytics HIV is a lentivirus and attacks immune system which leads to death. The continuous research has developed treatment for HIV which has made a separate market for HIV drugs. The HIV drug market is increasing due to increasing awareness and diagnosis rates. There are around five million people in low and middle income countries who do not have access to AIDS drugs. HIV is very common in Southern African region. Botswana and Zimbabwe are the most affected countries; HIV is the most underlying reason for more than one third of all deaths among children under age of five. In Japan, unwanted teen pregnancy is rising which may drive HIV drugs market in near future. Also the innovation of new drugs is driving HIV market; research continues to remain a significant unmet medical need for effective treatment. The report outlines major countries affected from HIV virus and death rates. It also gives an overview of HIV virus and therapies in demand. The report presents overview of global market, HIV in US, UK, Asia and Sub-Saharan Africa. It highlights major markets for HIV drugs with overall market value and major drugs revenue. The report discusses the opportunities prevailing in the HIV drugs market and issues affecting the growth. It also talks about competition prevalent in the market. It profiles major players with an overview of their business, key financials and business strategies. Table of Contents/List of Tables/List of Figures

MarketReports.com | Pharmaceuticals & Healthcare | Diseases and Treatment |  AIDS, HIV & STDs